Liver News and Research

RSS

CT-guided radiofrequency ablation effective in eradicating small malignant kidney tumors

A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients, report researchers from Wake Forest University Baptist Medical Center.

3 Aug 2007

Breakthrough in cancer treatment at Mount Sinai

A 32-year-old mother of two small children, who was recently diagnosed with metastatic stomach cancer, underwent surgery using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at The Mount Sinai Medical Center.

2 Aug 2007

Specific microRNA, called miR-21, helps liver cancer develop

New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.

2 Aug 2007

Erroneous messages on diet and breast cancer with potentially life threatening consequences

Recent media reports are suggesting that a diet high in fruits and vegetables and low in fat has no notable impact on breast cancer recurrence or death.

2 Aug 2007

Ibuprofen improves cognitive function in rats induced with chronic liver failure

Cognitive impairment is one of the neurological effects in patients with hepatic encephalopathy (abnormal brain function due to severe liver disease).

2 Aug 2007

New understanding of adult stem cell regulation

Forsyth Institute scientists have discovered an important mechanism for controlling the behavior of adult stem cells.

2 Aug 2007

Coffee and liver cancer

After lung and stomach cancer, liver cancer is the third largest cause of cancer deaths in the world.

2 Aug 2007

Magnetic resonance CAD is useful in diagnosing fibrosis of the liver

The study included 52 patients. The patient's MR images were reviewed by two radiologists, and their diagnosis was compared to the data that was provided by the CAD system.

2 Aug 2007

ARIUS announces allowance of US patent for lead anti-cancer antibody

ARIUS Research Inc., has announced that the Company has received notice from the United States Patent and Trademark Office that a key patent for its lead anti-CD44 drug candidate will issue on August 7th, 2007, as US Patent Number 7,252,821.

2 Aug 2007

Magnetic resonance CAD is useful in diagnosing fibrosis of the liver

Magnetic resonance CAD is useful in diagnosing fibrosis of the liver, according to a recent study conducted by radiologists at Gifu University School of Medicine in Gifu, Japan.

1 Aug 2007

New point of attack for future liver cancer treatments

The linking of two signalling pathways in the cells of liver tumours has a clear influence on their malignancy.

1 Aug 2007

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Killing cancerous tumors isn't easy, as anyone who has suffered through chemotherapy can attest.

1 Aug 2007

Interferon alpha and sorafenib combined work better than either alone against kidney cancer

A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.

1 Aug 2007

New oral contraceptive means 365 period free days a year

Women in the United States can now access the first low-dose combination contraceptive pill which stops their periods.

31 Jul 2007

Takeda responds to FDA recommendation on Actos

Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.

30 Jul 2007